Melanoma March has officially launched
5 February 2015
Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne.
The launch event held at Tonic House in Melbourne’s CBD revealed plans for the new funding. There will be 23 marches that are happening around Australia, with the first march kicking off in Melbourne on the 22nd February.
Professor Graham Mann, Research Director at MIA, explained how the Melanoma March campaign provides critical funding for our expert clinicians to get one step closer to finding a cure. He revealed the beneficiary of the 2015 initiative will be the next phase of the Melanoma Genome Project.
“Monies raised from last year’s Melanoma March campaign contributed to the world-first PD-1 Brain Metastases Trial - that is currently underway,” he said.
“Half of all patients diagnosed with stage 4 melanoma will develop brain metastases at some point during their illness. Until now, treatment has been unavailable and as such the clinicians at Melanoma Institute Australia are committed to developing new treatment options that provide potential hope to patients with brain metastases and could prove to be a significant step in finding a cure.
“Funds raised from the 2015 Melanoma March campaign will enable Melanoma Institute Australia and melanoma research centres around the nation to work together to launch a study which hopes to enable melanoma cells to be isolated, banked, distributed and tested against new treatments. This approach is a powerful way to capitalise on new knowledge from gene and immunity analysis that is showing where melanoma is vulnerable to attack.
Known as ‘Australia’s national cancer’, Australia has the highest incidence of melanoma in the world with over 12,500 new cases diagnosed each year, equating to one person dying every six hours from melanoma in Australia. Sadly, melanoma kills more young Australians (15-39 year-olds) than any other single cancer, proving why continual funding for research is key in addressing this devastating illness.
The Melbourne launch was also attended by former AFL icon and melanoma survivor, Tim McGrath as well as award winning musician Bob Corbett and channel Ten news presenter Brad McEwen.
To see where your local march is and how you can get involved to help us raise $1 million for melanoma research click here.
Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
MIA researchers feature on prestigious Highly Cited Researchers 2020 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Game On Mole is back this summer!
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
RCPA recognition for Professor Richard Scolyer.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.
Professor Georgina Long hands on baton of SMR Presidency
Professor Long cites as a highlight of her 2-year Presidency, the phenomenal research output by SMR members who have continued to lead the cancer field despite the impact of COVID-19.
City2Surf 2020
Join in the fun of the virtual event, and together we can run over melanoma!
Top melanoma experts from MIA
Melanoma Institute Australia features prominently in the latest ‘Expertise in Melanoma’ world rankings, released by Expertscape.
Melanoma Supportive Care Needs research study.
Participate in our online survey and help us understand the support needs of melanoma patients and carers.
New data reveals long-term benefit of adjuvant therapy for Stage III melanoma.
New online melanoma risk calculators critical to saving lives
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
Professor Richard Scolyer receives University of Sydney Alumni Award.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
Uniting together despite the distance
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
Professor Richard Scolyer recognised in The Pathologist's 2020 Power List.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
Important Update: Masks required at Poche Centre
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
A Critical Nexus:The Clinician and the Researcher.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
New online calculator launched to determine risk of spread of melanoma
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Queen's Birthday Honour for Professor Georgina Long
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
Danny's inspiring survival story
“I had a complete response within about six months. All of my tumours disappeared."
MIA in the spotlight at ASCO virtual conference
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
Professor Richard Scolyer achieves h-index of 100
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.